T Rowe Price Group, Inc.

Baltimore, MD Finance & insuranceNAICS 523900

Self-funded health planPlan year 2025Renews January
6,733Participants0% vs. prior year
$16.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 5Finance & insurance in MDBy participants

Overview

T Rowe Price Group, Inc. sponsors a self-funded health plan that covered 6,733 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
6,733 · prior year 6,747
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
T Rowe Price Group Inc. Health & Welfare Benefits Plan, plan 501 (6,733 participants); T Rowe Price Group Inc. Retiree Health Benefit Plan, plan 507 (278 participants)
Broker compensation
$203K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyLife9,461$3.9M—
Hartford Life and AccidentLong-term disability6,437$2.0M$30K
Aetna Life Insurance Co.Accident, Critical Illness and Hospital 3,463$1.3M$154K
Prudential Insurance Company of AmericaLong Term Care162$413K—
MetLife Legal PlansLegal564$132K$13K
Ace American Insurance CompanyBusiness Travel Accident6,397$38K$6K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$16.0M/ year

Estimated prescription spend: 6,733 participants × $2,371 national average per member. Usually higher once dependents are counted.

$415K–$1.0M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$121K–$303K
Lower-cost therapeutic alternatives$177K–$370K
Generic pricing vs. actual cost$77K–$230K
PBM contract terms$40K–$120K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
T Rowe Price Group, Inc.
Sponsor EIN
52-2264646
Plan numbers
501, 507
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 52-2264646 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
T. Rowe Price U.S. Retirement Program
Type
401(k) plan
Participants
12,087

About this data

Source: T Rowe Price Group, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with T Rowe Price Group, Inc..

Request a correction · Methodology